Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares OutstandingShares Outstanding
Ratios

Medifast (MED) Cost of Revenue (2016 - 2025)

Medifast's Cost of Revenue history spans 16 years, with the latest figure at $23.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 25.43% year-over-year to $23.0 million; the TTM value through Dec 2025 reached $110.6 million, down 29.93%, while the annual FY2025 figure was $110.6 million, 29.93% down from the prior year.
  • Cost of Revenue reached $23.0 million in Q4 2025 per MED's latest filing, down from $27.2 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $131.7 million in Q2 2022 to a low of $23.0 million in Q4 2025.
  • Average Cost of Revenue over 5 years is $71.1 million, with a median of $72.0 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: surged 113.14% in 2021, then tumbled 53.75% in 2024.
  • A 5-year view of Cost of Revenue shows it stood at $99.5 million in 2021, then grew by 4.12% to $103.6 million in 2022, then tumbled by 52.1% to $49.6 million in 2023, then plummeted by 37.99% to $30.8 million in 2024, then dropped by 25.43% to $23.0 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Cost of Revenue are $23.0 million (Q4 2025), $27.2 million (Q3 2025), and $28.9 million (Q2 2025).